Kai Feng
Jiangbei, 400020, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Development and internal validation of a radiomics-clinical combined model for predicting axillary pathological complete response in clinically node-positive breast cancer patients after neoadjuvant chemotherapy.
Journal: Frontiers in oncology
Published: May 09, 2026
Long-Term Outcome of No-Touch Radiofrequency Ablation for Treating AFP-Positive Small Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: February 20, 2026
Predictive Value of Age-Adjusted Charlson Comorbidity Index on Survival Outcomes of Hepatocellular Carcinoma Patients with Comorbidities Undergoing Radiofrequency Ablation.
Journal: Journal of hepatocellular carcinoma
Published: January 30, 2026
Relationship between resilience, social support, and mental health in breast cancer patients based on the four-quadrant health model.
Journal: Frontiers in public health
Published: January 27, 2026
Short- and Long-Term Outcomes of Radiofrequency Ablation for Early Hepatocellular Carcinoma with Liver Dysfunction.
Journal: Journal of hepatocellular carcinoma
Published: January 01, 2026
No-touch versus conventional radiofrequency ablation for treating solitary recurrent hepatocellular carcinoma ≤ 3 cm: a retrospective cohort study.
Journal: Journal of cancer research and clinical oncology
Published: November 04, 2025
Comment on "CT-based intratumoral and peritumoral radiomics to predict the treatment response to hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 in high-risk hepatocellular carcinoma cases: a multi-center study".
Journal: Hepatology international
Published: August 04, 2025
Comment on "Robotic beyond total mesorectal excision (bTME) for locally advanced and recurrent anorectal cancer: a systematic review".
Journal: Journal of robotic surgery
Published: July 31, 2025
Comment on "Population stratification using MASLD polygenic risk score improves severe liver disease prediction by clinical fibrosis scores".
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: July 29, 2025
Recombinant human type-5 adenovirus (H101) combined with radiofrequency ablation versus traditional radiofrequency ablation for hepatocellular carcinoma ≤ 3 cm: a phase III randomized controlled trial.
Journal: International journal of surgery (London, England)
Published: May 19, 2025
Last Updated: 09/26/2026